Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1984 1
1985 1
1988 1
1989 1
1992 3
1997 2
1998 7
1999 7
2000 2
2001 6
2002 11
2003 9
2004 5
2005 10
2006 6
2007 8
2008 7
2009 13
2010 4
2011 1
2012 5
2013 2
2014 6
2015 1
2016 3
2017 2
2018 5
2019 2
2020 10
2021 9
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

143 results
Results by year
Filters applied: . Clear all
Page 1
Balsalazide.
[No authors listed] [No authors listed] 2021 Nov 15. Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006–. 2021 Nov 15. Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006–. PMID: 30000534 Free Books & Documents. Review.
Although no information exists on the excretion of balsalazide into breastmilk, it is metabolized to the active drug mesalamine. ...Most experts consider mesalamine derivatives to be safe during breastfeeding.[1-4] If balsalazide is required by the mother, it is not …
Although no information exists on the excretion of balsalazide into breastmilk, it is metabolized to the active drug mesalamine. ...M …
Modern use of 5-aminosalicylic acid compounds for ulcerative colitis.
Le Berre C, Roda G, Nedeljkovic Protic M, Danese S, Peyrin-Biroulet L. Le Berre C, et al. Expert Opin Biol Ther. 2020 Apr;20(4):363-378. doi: 10.1080/14712598.2019.1666101. Epub 2019 Sep 18. Expert Opin Biol Ther. 2020. PMID: 31498003 Review.
Balsalazide.
Prakash A, Spencer CM. Prakash A, et al. Drugs. 1998 Jul;56(1):83-9; discussion 90. doi: 10.2165/00003495-199856010-00008. Drugs. 1998. PMID: 9664201 Review.
Balsalazide is a prodrug of mesalazine which has an inert carrier molecule instead of the sulfapyridine moiety of sulfasalazine. ...The tolerability profile of balsalazide is significantly better than that of sulfasalazine; 70% of sulfasalazine-intolerant patients w
Balsalazide is a prodrug of mesalazine which has an inert carrier molecule instead of the sulfapyridine moiety of sulfasalazine. ...T
Balsalazide in treating colonic diseases.
Tursi A. Tursi A. Expert Opin Drug Metab Toxicol. 2009 Dec;5(12):1555-63. doi: 10.1517/17425250903228842. Expert Opin Drug Metab Toxicol. 2009. PMID: 19708827 Review.
Balsalazide is the newer 5-aminosalicylic acid (5-ASA) prodrug which releases active 5-ASA only into the colon with minimal systemic absorption. The onset of action of this drug is variable, and it may take at least some days to reach clinical effectiveness. Clinical studi
Balsalazide is the newer 5-aminosalicylic acid (5-ASA) prodrug which releases active 5-ASA only into the colon with minimal systemic
Comparison of mesalazine and balsalazide in induction and maintenance of remission in patients with ulcerative colitis: a meta-analysis.
Rahimi R, Nikfar S, Rezaie A, Abdollahi M. Rahimi R, et al. Dig Dis Sci. 2009 Apr;54(4):712-21. doi: 10.1007/s10620-008-0428-2. Epub 2008 Aug 6. Dig Dis Sci. 2009. PMID: 18683049 Review.
In recent years, the 5-aminosalicylic acid-containing pro-drug balsalazide has been the focus of attention. AIM: To compare the efficacy and tolerance of balsalazide and mesalazine by meta-analysis. ...The number of patients with any adverse events and withdrawals b …
In recent years, the 5-aminosalicylic acid-containing pro-drug balsalazide has been the focus of attention. AIM: To compare the effic …
Balsalazide: a novel 5-aminosalicylate prodrug for the treatment of active ulcerative colitis.
Wiggins JB, Rajapakse R. Wiggins JB, et al. Expert Opin Drug Metab Toxicol. 2009 Oct;5(10):1279-84. doi: 10.1517/17425250903206996. Expert Opin Drug Metab Toxicol. 2009. PMID: 19743890 Review.
BACKGROUND: 5-Aminosalicylate (5-ASA) agents are the mainstay of oral therapy for ulcerative colitis (UC). Balsalazide, a prodrug of 5-ASA, has recently been approved for the treatment of UC. OBJECTIVE: To summarize current data on balsalazide and to discuss its imp …
BACKGROUND: 5-Aminosalicylate (5-ASA) agents are the mainstay of oral therapy for ulcerative colitis (UC). Balsalazide, a prodrug of …
Balsalazide: a review of its therapeutic use in mild-to-moderate ulcerative colitis.
Muijsers RB, Goa KL. Muijsers RB, et al. Drugs. 2002;62(11):1689-705. doi: 10.2165/00003495-200262110-00010. Drugs. 2002. PMID: 12109930 Review.
The systemic absorption of balsalazide and its metabolites is not required for the therapeutic efficacy of the drug, and has been demonstrated to be limited. ...In addition, balsalazide appears to have a faster onset of action than mesalazine. ...
The systemic absorption of balsalazide and its metabolites is not required for the therapeutic efficacy of the drug, and has been dem …
Balsalazide disodium for the treatment of ulcerative colitis.
Patil SA, Moss AC. Patil SA, et al. Expert Rev Gastroenterol Hepatol. 2008 Apr;2(2):177-84. doi: 10.1586/17474124.2.2.177. Expert Rev Gastroenterol Hepatol. 2008. PMID: 19072352 Review.
A number of formulations are available for the treatment of active ulcerative colitis, including encapsulated mesalazine and mesalazine in combination with other molecules. Balsalazide is an aminosalicylate prodrug that releases mesalazine in the colon, thus exerting its m …
A number of formulations are available for the treatment of active ulcerative colitis, including encapsulated mesalazine and mesalazine in c …
Safety of balsalazide therapy in the treatment of inflammatory bowel disease.
Baker DE. Baker DE. Rev Gastroenterol Disord. 2005 Summer;5(3):135-41. Rev Gastroenterol Disord. 2005. PMID: 16127348 Review.
This review will focus on newer safety information regarding the use of balsalazide in the treatment of patients with IBD. In general, mesalamine compounds such as balsalazide are better tolerated than sulfasalazine. ...Overall, balsalazide is well tolerated …
This review will focus on newer safety information regarding the use of balsalazide in the treatment of patients with IBD. In general …
Balsalazide-induced myocarditis.
Robertson E, Austin D, Jamieson N, Hogg KJ. Robertson E, et al. Int J Cardiol. 2008 Nov 28;130(3):e121-2. doi: 10.1016/j.ijcard.2007.07.033. Epub 2007 Sep 24. Int J Cardiol. 2008. PMID: 17889383
A 38 year-old man with ulcerative colitis recently treated with balsalazide was admitted with chest pain. Investigations demonstrated myocardial necrosis, ECG changes, echocardiographic wall motion abnormalities but normal epicardial coronary arteries and no LV scar on car …
A 38 year-old man with ulcerative colitis recently treated with balsalazide was admitted with chest pain. Investigations demonstrated …
143 results